Heart / Stroke-RelatedCardiologyFamily PracticeNeurologyNursingOBGYN & Women's HealthPulmonologyInternal MedicinePathologyGeriatricsPharmacyCardiovascular DiseasesHeart HealthGeneral HealthAspirin
HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
TUESDAY, Oct. 31, 2017 (HealthDay News) -- Aspirin resistance, measured using the Platelet Function Analyzer (PFA)-100 system, is associated with cardiovascular events in aspirin-treated patients, according to a study published online Oct. 21 in the Journal of Clinical Pharmacy and Therapeutics.
H.Y. Chen, M.D., from Taipei City Hospital in Taiwan, and P. Chou, Ph.D., from the Yang-Ming University School of Medicine in Taiwan, assessed aspirin resistance in 465 aspirin-treated patients from the outpatient department. Patients were followed for five years for hospitalization for any acute cardiovascular event.
The researchers found that 20 percent of the patients had aspirin resistance. There was a strong correlation for prior hospitalization history of cardiovascular events with aspirin resistance (P = 0.001). Cardiovascular events had developed in 11 patients with aspirin resistance (eight stroke and three myocardial infarction) and in nine patients without aspirin resistance (four stroke and five myocardial infarction) at the five-year follow-up (12.1 versus 2.4 percent; P < 0.001). A strong correlation was seen between aspirin resistance and cardiovascular events at the five-year follow-up in multivariate analysis (adjusted odds ratio, 4.28; 95 percent confidence interval, 1.64 to 11.2; P = 0.03).
"We posit that measuring aspirin resistance by PFA-100 may play a role in clinical cardiovascular prevention," the authors write.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at email@example.com with any questions.
Updated on May 29, 2022
Read this Next
Other Trending Articles